1. ALLA AKTIER
  2. NYHETER
  3. XBRANE BIOPHARMA

Xbrane Biopharma

Nyheter Xbrane Biopharma Nyheter alla bolag

XBRANE BIOPHARMA RELEASES ANNUAL AND SUSTAINABILITY REPORT FOR 2024

REG

Xbrane has released the company's 2024 Annual and Sustainability Report. The report summarizes business, financial performance and work on sustainability.

” We have taken important steps in advancing our biosimilar products through clinical trials and regulatory applications and remain focused on developing high-quality, affordable biological drugs for the benefit of patients around the world.” says Anders Tullgren, Chairman of the Board.

Xbrane Biopharma AB’s annual report for 2024 is now available at the company’s website, www.xbrane.com.
The annual report includes the corporate governance report and the sustainability report for 2024.
The Report is distributed to the shareholders and others that made such requests. It can also be ordered from Xbrane Biopharma at the following address:

Xbrane Biopharma AB
Scheeles väg 5
171 65 Solna
Sweden
Or via e-mail: ir@xbrane.com

Contacts

Martin Åmark, CEO
E: martin.amark@xbrane.com

Jane Benyamin, CFO/IR
E: jane.benyamin@xbrane.com

About Us

Xbrane Biopharma AB develops biological drugs based on a patented platform technology that provides significantly lower production costs compared to competing systems. Xbrane has a portfolio of biosimilar candidates targeting EUR 26 billion in estimated annual peak sales of the respective reference product. The lead candidate Ximluci® is granted market authorization approval in Europe and was launched during 2023. Xbrane’s head office is in Solna, just outside Stockholm. Xbrane is listed on Nasdaq Stockholm under the ticker XBRANE. For more information, visit www.xbrane.com  

This information is information that Xbrane Biopharma is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-03-31 14:20 CEST.

Attachments

Xbrane Annual And Sustainability Report 2024
xbra-2024-12-31-0-sv

Datum 2025-03-31, kl 14:20
Källa MFN
Bifogade filer
Xbrane Annual And Sustainability Report 2024
xbra-2024-12-31-0-sv
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.